Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis
US12136472B2 · kind B2 · utility
0Cited by
14References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2023 |
| Grant date | Nov 5, 2024 |
| Priority date | — |
| Expiry date | Sep 14, 2043 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH04L9/50
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.